Norepinephrine transporter density as a causative factor in alterations in MIBG myocardial uptake in NIDDM model rats

European Journal of Nuclear Medicine

Volumn 29, Issue 8, 2002, Pages 999-1005

  Kiyono, Yasushi ^a,b,c   Iida, Yasuhiko ^a,b,c   Kawashima, Hidekazu ^a,b,c   Ogawa, Mikako ^a,b,c   Tamaki, Nagara ^a,b,c   Nishimura, Hiroshi ^a,b,c   Saji, Hideo ^a,b,c  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

99mTc MIBI; 125I MIBG; GK rats; Non insulin dependent diabetes mellitus; Norepinephrine transporter

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 125; DESIPRAMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NORADRENALIN TRANSPORTER; TRACER; TRITIUM; (3 IODOBENZYL)GUANIDINE; IODINE 123; METAIODOBENZYLGUANIDINE I 123; NORADRENALIN; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; TECHNETIUM 99M HEXAKIS 2 METHOXY 2 ISOBUTYLISONITRILE; UNCLASSIFIED DRUG; COTRANSPORTER; DIAGNOSTIC AGENT; SLC6A2 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BINDING ASSAY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG UPTAKE; ELECTROCHEMICAL DETECTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE FIBER MEMBRANE; HEART VENTRICLE WALL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NORADRENALIN BLOOD LEVEL; PROTEIN FUNCTION; RADIATION ABSORPTION; RADIATION DOSE DISTRIBUTION; RADIOACTIVITY; RAT; TISSUE LEVEL; DRUG ABSORPTION; HEART MUSCLE METABOLISM; HEART SCINTISCANNING; ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; HEART MUSCLE; METABOLISM; REFERENCE VALUE; TISSUE DISTRIBUTION; WISTAR RAT;

3-IODOBENZYLGUANIDINE; ANIMAL; COMPARATIVE STUDY; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; DISEASE MODELS, ANIMAL; MALE; MYOCARDIUM; NOREPINEPHRINE; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; REFERENCE VALUES; SUPPORT, NON-U.S. GOV'T; SYMPORTERS; TECHNETIUM TC 99M SESTAMIBI; TISSUE DISTRIBUTION; ANIMALS; DIABETES MELLITUS, TYPE 2; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 0036320724     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-002-0798-1     Document Type: Article

References (40)

1. Metaiodobenzylguanidine scintigraphy of the heart: What have we learnt clinically?
2. Abnormal cardiac nerve function in syndrome X
3. Iodine 123-labeled metaiodobenzylguanidine imaging in heart disease
4. 123I]iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM. Comparison with cardiovascular reflex tests and relationship to left ventricular function
5. Metaiodobenzylguanidine imaging in diabetes mellitus: Assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia
6. Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy
7. Regional abnormality of iodine-123-MIBG in diabetic hearts
8. Diabetes and cardiovascular disease. The Framingham study
9. Capillary microaneurysms in the human diabetic heart
10. Evidence for cardiomyopathy in familial diabetes mellitus
11. The natural history of diabetic autonomic neuropathy
12. Development of diabetes in the non-obese NIDDM rat (GK rat)
13. Beta-cell insensitivity to glucose in the GK rat, a spontaneous non-obese model for type II diabetes
14. Insulin resistance in the GK rat: Decreased receptor number but normal kinase activity in liver
15. + channels is impaired in beta-cells of the GK rat. A new genetic model of NIDDM
16. 2+ channel activities in pancreatic beta cells of non-insulin-dependent diabetes mellitus GK rats
17. Myocardial imaging with a radioiodinated norepinephrine storage analog
18. Iodine-131 metaiodobenzylguanidine intra- and extravesicular accumulation in the rat heart
19. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function
20. Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine
21. Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters
22. 123I]iodobenzylguanidine in isolated rat heart
23. Evidence for reduction of norepinephrine uptake sites in the failing human heart
24. Upregulation of cardiac uptake 1 carrier in ischemic and nonischemic rat heart
25. 18F]fluoro-2-deoxy-D-glucose (FDG) in mammary tumors of antiestrogen-treated rats
26. 3H]desipramine binding in the peripheral and central nervous system: A specific site associated with the neuronal uptake of noradrenaline
27. Protein measurements with the Folin phenol reagent
28. Down-regulation of the noradrenaline transporter by interferon-alpha in cultured bovine adrenal medullary cells
29. Dual effects of intravenous anesthetics on the function of norepinephrine transporters
30. Peripheral nerve concentrations of glucose, fructose, sorbitol and myoinositol in diabetic and non-diabetic patients
31. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy
32. Complications: Neuropathy, pathogenetic considerations
33. The aetiology of diabetic neuropathy: The combined roles of metabolic and vascular defects
34. Diabetic neuropathies
35. Acute regulation of norepinephrine transport. I. Protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells
36. Acute regulation of norepinephrine transport. II. PKC-modulated surface expression of human norepinephrine transporter proteins
37. Molecular physiology and regulation of catecholamine transporters
38. Reflex sympathetic augmentation of left-ventricular inotropic state in the conscious dog
39. Patterns of sympathetic nerve projections onto the canine heart
40. Anatomy of human extrinsic cardiac nerves and ganglia